K Ground Ventures

K Ground Ventures is a science and technology commercialization investment platform.

Namhoon Cho

General Partner and CEO

14 past transactions

Soomvi

Venture Round in 2024
Soomvi is a company focused on the industrial drone market, specializing in marine lifesaving systems. The firm develops advanced drones equipped with technology that enables them to recognize and learn from their environment, ensuring enhanced security and operational performance. These drones feature a sensor-isolated and vibration-resistant design, which contributes to their reliability in various applications. Soomvi's drones also offer real-time synchronization and communication capabilities, allowing for effective monitoring of flight information and backup control system operations. This technology positions Soomvi as a key player in providing innovative solutions for industrial needs, particularly in maritime safety.

Kookmin Bio

Series B in 2024
Kookmin Bio is a biotechnology company focused on creating bio-food and pharmaceutical materials. The company specializes in developing microbiome-regulating materials and new drugs aimed at preventive medicine. Kookmin Bio employs advanced strain development and fermentation production technology to produce biopharmaceutical materials that address imbalances in intestinal microflora. By prioritizing health and well-being, Kookmin Bio aims to enhance the quality of life for its patients through innovative solutions in the biotechnology sector.

searchM

Venture Round in 2024
searchM is a digital marketing and advertising company.

Daton

Seed Round in 2024
Daton is an IoT solution provider specializing in artificial intelligence and IoT solutions. The company offers products like Tech-See, an AI-driven video monitoring system, and Xpotti, an intelligent security solution for schools and public areas. Daton focuses on enhancing safety and efficiency across various sectors through advanced AI technologies.

Ingenium Therapeutics

Series A in 2023
Ingenium Therapeutics is a treatment development company focused on advancing anti-cancer immunotherapy. The firm specializes in utilizing natural killer (NK) cells, a type of immune cell found in the human body, to create therapies aimed at treating difficult cases of leukemia. By leveraging robust foundational research, Ingenium Therapeutics aims to provide cancer patients with effective immuno-anticancer drugs that function optimally within the immune environment. The company's work centers on enhancing the clinical impact of NK cell therapies to address unmet medical needs in cancer treatment.

Mitoimmune Therapeutics

Venture Round in 2023
Mitoimmune Therapeutics is a biotechnology company focused on drug research and development aimed at addressing mitochondrial dysfunction and related cellular disorders. The company is dedicated to creating treatments for diseases associated with mitochondrial dysfunction, including those that are necrotic and inflammatory in nature. Through its innovative approach, Mitoimmune Therapeutics seeks to enhance the quality of life for patients by providing effective therapeutic solutions for complex health issues linked to mitochondrial health.

Creamo

Venture Round in 2023
Creamo specializes in the development of educational block games designed to enhance children's learning and creativity. The company offers physical coding kits and interactive smart blocks that utilize Internet of Things (IoT) technology. These toys encourage purposeful play with real objects, fostering an engaging environment that promotes cognitive development and problem-solving skills. By integrating play with learning, Creamo aims to provide children with tools that not only entertain but also empower them to think critically and creatively.

Ingenium Therapeutics

Seed Round in 2022
Ingenium Therapeutics is a treatment development company focused on advancing anti-cancer immunotherapy. The firm specializes in utilizing natural killer (NK) cells, a type of immune cell found in the human body, to create therapies aimed at treating difficult cases of leukemia. By leveraging robust foundational research, Ingenium Therapeutics aims to provide cancer patients with effective immuno-anticancer drugs that function optimally within the immune environment. The company's work centers on enhancing the clinical impact of NK cell therapies to address unmet medical needs in cancer treatment.

Yellowknife

Seed Round in 2021
Yellowknife is a company that specializes in enhancing vehicle experiences through a custom digital cluster sharing and usage platform. It aims to provide travel experiences tailored to various forms of future transportation. The company offers a mobility display that allows users to customize their vehicle interfaces. This includes a screen interface that can be personalized with a cover skin, in addition to the standard liquid-crystal display digital instrument panel provided by vehicle manufacturers. Yellowknife focuses on meeting the unique display preferences of its users, thereby improving the overall driving experience.

EndoRobotics

Series A in 2021
EndoRobotics is a healthcare company focused on advancing endoscopic surgery through the development of specialized robotic technology. The company is working on an endoscopic surgical assist robot along with a range of associated surgical instruments. These innovations aim to enhance the capabilities of endoscopic procedures, offering improved treatment options within the healthcare industry. By integrating robotics into endoscopy, EndoRobotics seeks to provide more effective and precise therapeutic interventions.

Nemesis

Seed Round in 2021
Nemesis provides bio and medical device vendors and service providers with Intelligent biosignal processing solutions. Nemesis has technologies like biosensors, bio-signal processing, and wireless communication, which provide compact, low-power, and accurate semiconductor solutions that anyone can use. Nemesis semiconductor-based intelligent bio signal processing solution can be expanded to diagnose biomarkers in areas such as heart rate, electrocardiogram, blood pressure, and virus detection. Nemesis will do everything possible to improve the quality of our partners' products and services as a result of this.

YPER

Series A in 2020
YPER is a vehicle management and car wash app.

Solomonster

Seed Round in 2020
Advertising agency, digital content development, supply, pop culture art planning/e-commerce

CatackH

Venture Round in 2020
The world's first CFRP recycling company by chemical decomposition technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.